MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
MindWalk Holdings Corp. (HYFT)
Company Research
Source: Business Wire
Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics marketHYFT®-driven discovery supports co-administration of MindWalk’s proprietary companion therapeutic with the Company’s GLP-1 receptor agonist AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced a major advancement of its AI-designed GLP-1 therapeutics program. New insights from the Company’s LensAI™ platform reveal a previously unrecognized connection between GLP-1 biology and a second, non-overlapping pathway central to healthy aging and systemic resilience. The findings support a first-in-class dual-pathway regimen in which MindWalk’s proprietary companion therapeutic is co-administered with its GLP-1 receptor agonists (GLP-1RAs) to engage both mechanisms in concert. To the Company’s knowledge, no approved or marketed drugs u
Show less
Read more
Impact Snapshot
Event Time:
HYFT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HYFT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HYFT alerts
High impacting MindWalk Holdings Corp. news events
Weekly update
A roundup of the hottest topics
HYFT
News
- MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025 [Yahoo! Finance]Yahoo! Finance
- MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025Business Wire
- MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth StrategyBusiness Wire
- MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial ExpansionBusiness Wire
- MindWalk Holdings announces 2.3M share buyback program [Seeking Alpha]Seeking Alpha
HYFT
Earnings
- 9/15/25 - Miss
HYFT
Sec Filings
- 11/13/25 - Form 6-K
- 11/7/25 - Form 6-K
- 11/7/25 - Form 424B5
- HYFT's page on the SEC website